4 min read
|
Saved October 29, 2025
|
Copied!
Do you care about this?
Sonnet BioTherapeutics has announced a merger with Rorschach I LLC, resulting in the formation of Hyperliquid Strategies, which will launch a HYPE treasury strategy. The deal, valued at $888 million, will include the issuance of 12.6 million HYPE tokens and $305 million in cash, with participation from several strategic investors.
If you do, here's more
Click "Generate Summary" to create a detailed 2-4 paragraph summary of this article.
Questions about this article
No questions yet.